Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 6090749, 7 pages
http://dx.doi.org/10.1155/2016/6090749
Research Article

Diabetic Retinopathy Is Strongly Predictive of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes

1Department of Neurology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan
2Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan
3Department of Biological Science, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan
4Department of Neurology, Xiamen Chang Gung Memorial Hospital, Xiamen, Fujian, China
5Division of Metabolism, Department of Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan

Received 20 November 2015; Revised 7 January 2016; Accepted 10 January 2016

Academic Editor: Nikolaos Papanas

Copyright © 2016 Chih-Cheng Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. J. Ewing, C. N. Martyn, R. J. Young, and B. F. Clarke, “The value of cardiovascular autonomic function tests: 10 years experience in diabetes,” Diabetes Care, vol. 8, no. 5, pp. 491–498, 1985. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Kempler, S. Tesfaye, N. Chaturvedi et al., “Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study,” Diabetic Medicine, vol. 19, no. 11, pp. 900–909, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Low, “Diabetic autonomic neuropathy,” Seminars in Neurology, vol. 16, no. 2, pp. 143–151, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. I. A. D. O'Brien, J. P. O'Hare, I. G. Lewin, and R. J. M. Corrall, “The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: a controlled study based on heart rate variability,” Quarterly Journal of Medicine, vol. 61, no. 234, pp. 957–967, 1986. View at Google Scholar · View at Scopus
  5. V. Spallone, D. Ziegler, R. Freeman et al., “Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 7, pp. 639–653, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Tesfaye, A. J. M. Boulton, P. J. Dyck et al., “Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments,” Diabetes Care, vol. 33, no. 10, pp. 2285–2293, 2010. View at Publisher · View at Google Scholar
  7. D. R. Witte, S. Tesfaye, N. Chaturvedi, S. E. M. Eaton, P. Kempler, and J. H. Fuller, “Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus,” Diabetologia, vol. 48, no. 1, pp. 164–171, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. B. P. M. Imholz, G. A. Van Montfrans, J. J. Settels, G. M. A. Van Der Hoeven, J. M. Karemaker, and W. Wieling, “Continuous non-invasive blood pressure monitoring: reliability of Finapres device during the Valsalva manoeuvre,” Cardiovascular Research, vol. 22, no. 6, pp. 390–397, 1988. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Sandroni, E. E. Benarroch, and P. A. Low, “Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure,” Journal of Applied Physiology, vol. 71, no. 4, pp. 1563–1567, 1991. View at Google Scholar · View at Scopus
  10. “Assessment: clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology,” Neurology, vol. 46, no. 3, pp. 873–880, 1996.
  11. D. J. Ewing, I. W. Campbell, and B. F. Clarke, “The natural history of diabetic autonomic neuropathy,” Quarterly Journal of Medicine, vol. 49, no. 193, pp. 95–108, 1980. View at Google Scholar · View at Scopus
  12. A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman, “Diabetic autonomic neuropathy,” Diabetes Care, vol. 26, no. 5, pp. 1553–1579, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. P. A. Low, “Testing the autonomic nervous system,” Seminars in Neurology, vol. 23, no. 4, pp. 407–421, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. P. J. Dyck, P. C. O'Brien, W. J. Litchy, C. M. Harper, J. R. Daube, and P. J. B. Dyck, “Use of percentiles and normal deviates to express nerve conduction and other test abnormalities,” Muscle and Nerve, vol. 24, no. 3, pp. 307–310, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. P. A. Low, “Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure,” Mayo Clinic Proceedings, vol. 68, no. 8, pp. 748–752, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. C. P. Wilkinson, F. L. Ferris III, R. E. Klein et al., “Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales,” Ophthalmology, vol. 110, no. 9, pp. 1677–1682, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. P. A. Low, L. M. Benrud-Larson, D. M. Sletten et al., “Autonomic symptoms and diabetic neuropathy: a population-based study,” Diabetes Care, vol. 27, no. 12, pp. 2942–2947, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Pappachan, J. Sebastian, B. C. Bino et al., “Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis,” Postgraduate Medical Journal, vol. 84, no. 990, pp. 205–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Klein, B. E. K. Klein, and S. E. Moss, “The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years,” Archives of Ophthalmology, vol. 102, no. 4, pp. 527–532, 1984. View at Publisher · View at Google Scholar · View at Scopus
  20. K. M. West, L. J. Erdreich, and J. A. Stober, “A detailed study of risk factors for retinopathy and nephropathy in diabetes,” Diabetes, vol. 29, no. 7, pp. 501–508, 1980. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Cohen, B. W. Jeffers, D. Faldut, M. Marcoux, and R. W. Schrier, “Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM),” Muscle & Nerve, vol. 21, no. 1, pp. 72–80, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Schmid, B. Schaan, F. Cecconello, T. Maestri, and C. Neumann, “Proliferative diabetic retinopathy is related to cardiovascular autonomic neuropathy in non-insulin-dependent diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 29, no. 3, pp. 163–168, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Moran, W. Palmas, L. Field et al., “Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes,” Diabetes Care, vol. 27, no. 4, pp. 972–977, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Savage, R. O. Estacio, and R. W. Schrier, “Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM,” Diabetes Care, vol. 19, no. 11, pp. 1243–1248, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. M. Smulders, A. Jager, J. Gerritsen et al., “Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasian subjects with impaired glucose tolerance or type 2 diabetes: the Hoorn study,” Diabetes Care, vol. 23, no. 9, pp. 1369–1374, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. N. G. Sterner, H. Nilsson, U. Rosén, B. Lilja, and G. Sundkvist, “Relationships among glomerular filtration rate, albuminuria, and autonomic nerve function in insulin-dependent and non-insulin-dependent diabetes mellitus,” Journal of Diabetes and Its Complications, vol. 11, no. 3, pp. 188–193, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. R. J. Parmer, J. H. Cervenka, and R. A. Stone, “Baroreflex sensitivity and heredity in essential hypertension,” Circulation, vol. 85, no. 2, pp. 497–503, 1992. View at Publisher · View at Google Scholar · View at Scopus
  28. R. D. Hoeldtke, K. D. Bryner, D. R. McNeill et al., “Nitrosative stress, uric Acid, and peripheral nerve function in early type 1 diabetes,” Diabetes, vol. 51, no. 9, pp. 2817–2825, 2002. View at Publisher · View at Google Scholar
  29. J. Sundström, L. Sullivan, R. B. D'Agostino, D. Levy, W. B. Kannel, and R. S. Vasan, “Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence,” Hypertension, vol. 45, no. 1, pp. 28–33, 2005. View at Publisher · View at Google Scholar · View at Scopus